Cargando…

Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation

INTRODUCTION: Esophageal adenocarcinoma incidence has increased significantly despite surveillance endoscopy for Barrett’s esophagus (BE) and gastric acid supression medications. This prospective, cohort study’s aims were to determine the long-term efficacy of proton-pump inhibitors twice daily (PPI...

Descripción completa

Detalles Bibliográficos
Autor principal:	Snady, Harry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Gastroenterology & Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228298/ https://www.ncbi.nlm.nih.gov/pubmed/37232568 http://dx.doi.org/10.1080/07853890.2023.2191002

Ejemplares similares

Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease
por: Choden, Tenzin, et al.
Publicado: (2023)

The prospective multiple-centre randomized controlled clinical study of high-dose amoxicillin-proton pump inhibitor dual therapy for H. pylori infection in Sichuan areas
por: Shen, Cheng, et al.
Publicado: (2022)

Unexplained abdominal pain as a driver for inappropriate therapeutics: an audit on the use of intravenous proton pump inhibitors
por: Lai, Pauline Siew Mei, et al.
Publicado: (2014)

Evolution of proton pump inhibitor prescribing from 2017 to 2021 at 14 secondary and tertiary hospitals in China：a multicentre cross-sectional study
por: Zeng, Min, et al.
Publicado: (2023)

Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice
por: Broide, Efrat, et al.
Publicado: (2020)

Proton Pump Inhibitors: The Culprit for Barrett’s Esophagus?
por: Alsalahi, Omran, et al.
Publicado: (2015)

Coding of Barrett’s oesophagus with high-grade dysplasia in national administrative databases: a population-based cohort study
por: Chadwick, Georgina, et al.
Publicado: (2017)

NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case–control study
por: Masclee, Gwen M C, et al.
Publicado: (2015)

Factors influencing participation in randomised clinical trials among patients with early Barrett’s neoplasia: a multicentre interview study
por: Peerally, Mohammad Farhad, et al.
Publicado: (2023)

Does Smoking Cannabis Increase the Risk of Barrett’s Esophagus?
por: Levy, Joshua, et al.
Publicado: (2020)

A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett’s oesophagus to oesophageal adenocarcinoma
por: Nieto, Tom, et al.
Publicado: (2018)

Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol
por: Nieto, T, et al.
Publicado: (2016)

Artificial Intelligence in the Detection of Barrett's Esophagus: A Systematic Review
por: Patel, Akash, et al.
Publicado: (2023)

Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma
por: Valdovinos-Andraca, Francisco, et al.
Publicado: (2023)

Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2022)

Proton Pump Inhibitors Diminish Barrett’s Esophagus Length: Our Experience
por: Gashi, Zaim, et al.
Publicado: (2018)

Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study
por: Amin, Neeta B, et al.
Publicado: (2022)

An Urban Center Experience Exploring Barriers to Adherence to Endoscopic Surveillance for Non-Dysplastic Barrett’s Esophagus
por: Isseh, Mahmoud, et al.
Publicado: (2021)

Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
por: Takeda, Yasuhito, et al.
Publicado: (2015)

Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea
por: Jo, Hyun Jin, et al.
Publicado: (2013)

Sub-milliSievert ultralow-dose CT colonography with iterative model reconstruction technique
por: Lambert, Lukas, et al.
Publicado: (2016)

Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion
por: Weersink, Rianne A, et al.
Publicado: (2016)

Outcomes following feeding gastrostomy (FG) insertion in patients with learning disability: a retrospective cohort study using the health improvement network (THIN) database
por: Harvey, Philip R, et al.
Publicado: (2019)

Different doses of prucalopride in treating chronic idiopathic constipation: a meta-analysis and Bayesian analysis
por: Yang, Tao, et al.
Publicado: (2021)

Seminar-case learning model improves clinical teaching: a prospective randomized controlled trial
por: Li, Peiyuan, et al.
Publicado: (2021)

Direct Mucosal-Side Fibrosis Cutting for Salvage Endoscopic Submucosal Dissection of Secondary Barrett's Neoplasia Adjacent Multiband Resection Scars
por: Zimmer, Vincent, et al.
Publicado: (2022)

Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis
por: Kennedy, Oliver John, et al.
Publicado: (2017)

Lengthening adalimumab dosing interval in quiescent Crohn’s disease patients: protocol for the pragmatic randomised non-inferiority LADI study
por: Smits, L J T, et al.
Publicado: (2020)

Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study
por: Tang, Xiaoping, et al.
Publicado: (2022)

Systematic review and meta-analysis of risk scores in prediction for the clinical outcomes in patients with acute variceal bleeding
por: Yang, Ling, et al.
Publicado: (2021)

25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study
por: Yoshihara, Takeo, et al.
Publicado: (2015)

Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
por: Ma, Christopher, et al.
Publicado: (2017)

Prediction of severity and outcomes of colon ischaemia using a novel prognostic model: a clinical multicenter study
por: Ai, Xinbo, et al.
Publicado: (2021)

Dose–response association between physical activity and non-alcoholic fatty liver disease: a case–control study in a Chinese population
por: Li, YangFan, et al.
Publicado: (2019)

Accelerated induction regimens of TNF-alpha inhibitors in patients with inflammatory bowel disease: a scoping review protocol
por: Johnston, Amy, et al.
Publicado: (2018)

Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial
por: Voskens, Caroline J, et al.
Publicado: (2021)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
por: Paulides, Emma, et al.
Publicado: (2022)

Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a ‘real-world’ view
por: McFarlane, Michael, et al.
Publicado: (2016)

Heterogeneity in outcome assessment for inflammatory bowel disease in routine clinical practice: a mixed-methods study in a sample of English hospitals
por: Razanskaite, Violeta, et al.
Publicado: (2021)

Impact of old age on resectable colorectal cancer outcomes
por: Fu, Jianfei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cfm3ha5tu0een5gsnn0mm39pid